Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Week in Review

Дата публикации: 26-06-2026 04:26:26

Federal judge halts arrests at immigration courts, Department of Justice cracks down on health care fraud, and more…
The post Week in Review first appeared on The Regulatory Review.

Основное содержимое страницы с новостью.

Federal judge halts arrests at immigration courts, Department of Justice cracks down on health care fraud, and more…

IN THE NEWS 

  • A federal judge issued an order that prohibits the federal government from making immigration arrests at immigration courts. The Trump Administration had been making arrests outside courtrooms following immigration hearings since early in the President’s second term. Judge P. Casey Pitts of the U.S. District Court for the Northern District of California cited the potential “chilling effect” of these arrests on defendants’ attendance at hearings as part of the reasoning for his decision. Although an earlier decision banned such arrests in New York State, this decision immediately takes effect across the country.
  • A federal judge on the 

    U.S. District Court for the District of Massachusettsallowed

     a lawsuit to continue after the federal government tried to dismiss the case against an 

    executive order

     issued by President Donald J. Trump that would restrict the use of mail-in ballots for future elections. Judge 

    Indira Talwani found

    that states would struggle to update the election procedures in time for the November elections due to the requirements that each state must take under the executive order.. Judge Talwani noted that some states have already begun to prepare for the upcoming election, and the executive order would add multiple steps to the election preparation in those states. Judge Talwani 

    dismissed

     claims relating to any elections after November 2026, however, stating that there will be enough time for states to implement the executive order after November.

  • The 

    U.S. Department of Justiceannounced

     the 2026 National Health Care Fraud Takedown, charging 455 defendants across 45 states with allegedly submitting over $6.5 billion in false claims to Medicare and Medicaid. The alleged schemes

    included

     fraudulent billing, providing medically unnecessary services, and illegal distributing opioids. The Takedown involved what the Justice Department

    described

     as unprecedented international cooperation, resulting in the apprehension of fugitive defendants in Estonia, the Philippines, and Cyprus, as well as the seizure of over $182 million in cash and other assets. The Justice Department

    described

     the action as the largest Medicaid fraud enforcement operation in its history.

  • The Chicago Mercantile Exchange (CME) filed a 

    lawsuit

     in the 

    U.S. District Court for the District of Columbia

     against the 

    Commodity Futures Trading Commission

     (CFTC) and its Chairman 

    Michael Selig

    challenging

     the Commission’s 

    order

     approving Kalshi’s BTCPERP contract as a futures contract rather than a swap. The 

    BTCPERP contract

     is a cash-settled Bitcoin derivative that tracks the real-time U.S. dollar price of Bitcoin with no fixed expiration date. The distinction between 

    futures

     and 

    swaps

     matters because swaps face stricter regulation, including more demanding reporting requirements and less favorable tax treatment. CME 

    contended

     that the CFTC departed from its prior policy of regulating such contracts as swaps without acknowledging or explaining that reversal and asked the district court to strike down the order.

  • The FDA

    approved

    the first single dose generic treatment for influenza, for use by patients who are at least five years old. The manufacturer, Genetech, Inc., previously trademarked the medication under the name Xofluza. In the United States, 90% of prescriptions are 

    filled

    using the generic medication, rather than the name brand. In its press release the FDA

    stated

     that approving the generic medication would lead to a growth in competition in the marketplace for flu medication, which could lower cost of the medication for patients.

  • The U.S. Supreme Court ruled in a 6-3 

    decision

     that 

    U.S. Customs and Border Protection

    agents may place green card holders who face criminal charges on parole when the green card holders attempt to enter the United States. When green card holders are placed on parole, they

    lose

     access to certain legal rights afforded to them by the green card, such as the right to work. Immigrant advocates

    argued

     that border agents need clear evidence to place a green card holder on parole, while the government 

    claimed

    that border agents only need a “good faith belief” that the green card holder has a qualifying offence. The dissenting justices

    stated

     this decision could lead to green card holders losing their status based on assumptions, with later court dates set, allowing the prosecution to gather evidence in the meantime.

  • The 

    National Collegiate Athletic Association’sDivision I cabinetapproved

     a new age-based eligibility model allowing Division I athletes a continuous five-year eligibility period for intercollegiate sports, beginning when they first enroll full time in college or at the start of the academic year following their 19th birthday, instead of the previous standard of four seasons within five years. The rule 

    replaced

     the prior eligibility framework with an age-based model and eliminates redshirts, sport-specific eligibility rules, and eligibility extension waivers. Current athletes and students enrolling in fall 2026 may 

    choose

    the most favorable eligibility rule, while the new model exclusively applies to students enrolling in fall 2027 or later. Athletes have reportedly filed multiple lawsuits seeking an additional year of eligibility under the prior standard.

WHAT WE’RE READING 

  • In a recent Center for American Progress (CAP) reportBobby Kogan, the senior director of federal budget policy at CAP, and Jared Bernstein, a senior fellow at CAP, identified the impacts of the increased national debt on those living in the United States and argued that policymakers should not rely on artificial intelligence (AI) to solve the growing national debt gap. Kogan and Bernstein claimed that although wages will still increase by 2055, they estimated a 45 percent increase rather than a 50 percent increase given a lower national debt. They recommended that Congress take action and not rely on AI productivity growth to close the rising national debt. They argued that Congress has to enacted policies now that will close the gap. The problem with Congress acting after the gaps grows is that Congress will be forced to close the gap quickly by raising taxes by 15% or cutting programs such as Medicare or Medicaid.
  • In a recent

    Brookings Institutioncommentary

    ,

    Peter Dreier,

    the E.P. Clapp Distinguished Professor of Politics at

    Occidental College

    , and

    Mike Bonin

    , the executive director of the

    Pat Brown Institute at Cal State Los Angeles

    ,

    examined

     the integrity of California’s mail-in ballot system amid President Trump’s claims of election fraud. Dreier and Bonin

    argued

     that California’s lengthy counting process reflects the state’s rigorous signature verification, ballot curing, and postmark deadline requirements rather than mismanagement, and that President Trump’s claims of cheating following the June 2026 Los Angeles mayoral primary were unfounded. Dreier and Bonin 

    contended

     that a greater threat to election integrity would come from a pending U.S. Supreme Court decision that could prevent states from counting ballots received after Election Day, potentially disenfranchising over 400,000 California voters. Dreier and Bonin

    recommended

     increasing funding for local election offices to speed up ballot processing rather than weakening California’s election safeguards.

  • In a recent 

    report

    , the

    U.S. Governmental Accountability Office

     argued that better coordination between federal agencies is necessary to identify and serve rural American communities that currently lack access to adequate drinking water and wastewater infrastructure. Due to statutory constraints on its regulatory power, the 

    U.S. Environmental Protection Agencycan

     only collect comprehensive data on water systems that are public, have at least 15 service connections, or “regularly serve at least 25 people.” Similarly, the

    U.S. Department of Agriculture

     only 

    collects

     data necessary to manage its grants and loans. GAO contended that joint efforts such as 

    Closing America’s Wastewater Gap

    , a pilot program 

    led

    by both agencies aimed at outreach and data sharing, can bridge gaps and help identify and address infrastructure problems in communities that remain unserved.

EDITOR’S CHOICE 

  • In an essay in The Regulatory Review, Mikaela Wells, Cross Conrad, and Karson Taylor evaluated the ethical considerations of FDA’s accelerated approval mechanism for life-saving medication. They considered the implications of allowing terminally ill patients to receive accelerated approval for medication without the medication going through the traditional FDA approval process. Rather than relying on the onerous, often decade-long process normally used, researchers now can look to the surrogate endpoint, a medical indicator that a treatment is “reasonably likely to predict clinical benefit,” to seek approval for a particular medicine. Critics of the policy argue that the lower standard and delays in confirmatory studies increase drug prices and may lead to an increase in unknown side effects or other poor outcomes for patients.
Related Essays

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Week in Review07.7912-06-2026
2Week in Review09.8410-07-2026
3Week in Review07.903-07-2026
4Week in Review08.129-05-2026
5Week in Review08.1605-06-2026
6Week in Review08.124-07-2026
7Week in Review07.5917-07-2026
8Week in Review07.2815-05-2026
9Week in Review07.3522-05-2026
10Week in Review07.7208-05-2026

Классификация: Мнения. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.79. Источник: www.theregreview.org.